Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

Abstract Background Recent studies reported that sodium glucose cotransporter 2 (SGLT2) inhibitors can potentially reduce the risk of cardiovascular mortality in patients with type 2 diabetes mellitus (T2DM). However, there is little or no information on the therapeutic effects of SGLT2 inhibitors o...

Full description

Bibliographic Details
Main Authors: Fumika Shigiyama, Naoki Kumashiro, Masahiko Miyagi, Kayoko Ikehara, Eiichiro Kanda, Hiroshi Uchino, Takahisa Hirose
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Cardiovascular Diabetology
Subjects:
Dapagliflozin
Endothelial function
Type 2 diabetes
Online Access:http://link.springer.com/article/10.1186/s12933-017-0564-0

Internet

http://link.springer.com/article/10.1186/s12933-017-0564-0

Similar Items